• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 9-23 of 133 results

6 Mandatory Notice: Mandatory Notice

Document IPR2017-01034, No. 6 Mandatory Notice - Mandatory Notice (P.T.A.B. Mar. 30, 2017)

cite Cite Document
Analyze

5 Power of Attorney: Power of Attorney

Document IPR2017-01034, No. 5 Power of Attorney - Power of Attorney (P.T.A.B. Mar. 30, 2017)

cite Cite Document
Analyze

1 Exhibit List: Petitioners Exhibit List

Document IPR2017-01034, No. 1 Exhibit List - Petitioners Exhibit List (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

3 Power of Attorney: Petitioners Power of Attorney

Document IPR2017-01034, No. 3 Power of Attorney - Petitioners Power of Attorney (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

Controlled Release and Taste Masking Oral Pharmaceutical Composition

Docket 13/617,138, U.S. Patent Application (Sept. 14, 2012)

cite Cite Docket
Analyze

1054 Exhibit: MYLAN EX 1054 Specification of 12210,969 application

Document IPR2017-01034, No. 1054-45 Exhibit - MYLAN EX 1054 Specification of 12210,969 application (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1051 Exhibit: MYLAN EX 1051 LW Doner

Document IPR2017-01034, No. 1051-42 Exhibit - MYLAN EX 1051 LW Doner (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1025 Exhibit: MYLAN EX 1025 FDA Inactive Ingredient Guide 19961997

Document IPR2017-01034, No. 1025-19 Exhibit - MYLAN EX 1025 FDA Inactive Ingredient Guide 19961997 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1009 Exhibit: MYLAN EX 1009 US Patent No 5,811,388

Document IPR2017-01034, No. 1009-6 Exhibit - MYLAN EX 1009 US Patent No 5,811,388 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1040 Exhibit: MYLAN EX 1040 US Patent No 5,849,327

Document IPR2017-01034, No. 1040-31 Exhibit - MYLAN EX 1040 US Patent No 5,849,327 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1015 Exhibit: MYLAN EX 1015 Amendment After Final

Document IPR2017-01034, No. 1015-12 Exhibit - MYLAN EX 1015 Amendment After Final (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1044 Exhibit: MYLAN EX 1044 See A Blume, B Arnold, HU Weltzien,

Document IPR2017-01034, No. 1044-35 Exhibit - MYLAN EX 1044 See A Blume, B Arnold, HU Weltzien, (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1026 Exhibit: MYLAN EX 1026 Handbook of Pharmaceutical Excipients

Document IPR2017-01034, No. 1026-20 Exhibit - MYLAN EX 1026 Handbook of Pharmaceutical Excipients (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1008 Exhibit: MYLAN EX 1008 US Patent No 5,681,584

Document IPR2017-01034, No. 1008-5 Exhibit - MYLAN EX 1008 US Patent No 5,681,584 (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze

1016 Exhibit: MYLAN EX 1016 Amendment and Response to Office Action

Document IPR2017-01034, No. 1016-13 Exhibit - MYLAN EX 1016 Amendment and Response to Office Action (P.T.A.B. Mar. 9, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 8 9 10 >>